ATE219943T1 - Antirestenoses protein - Google Patents

Antirestenoses protein

Info

Publication number
ATE219943T1
ATE219943T1 AT94921886T AT94921886T ATE219943T1 AT E219943 T1 ATE219943 T1 AT E219943T1 AT 94921886 T AT94921886 T AT 94921886T AT 94921886 T AT94921886 T AT 94921886T AT E219943 T1 ATE219943 T1 AT E219943T1
Authority
AT
Austria
Prior art keywords
pct
date
serp
sec
antirestenose
Prior art date
Application number
AT94921886T
Other languages
English (en)
Inventor
D Grant Mcfadden
Alexandra Lucas
Original Assignee
Viron Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viron Therapeutics Inc filed Critical Viron Therapeutics Inc
Application granted granted Critical
Publication of ATE219943T1 publication Critical patent/ATE219943T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Passenger Equipment (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT94921886T 1994-04-08 1994-04-08 Antirestenoses protein ATE219943T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/003895 WO1995027503A1 (en) 1994-04-08 1994-04-08 Antirestenosis protein

Publications (1)

Publication Number Publication Date
ATE219943T1 true ATE219943T1 (de) 2002-07-15

Family

ID=22242439

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94921886T ATE219943T1 (de) 1994-04-08 1994-04-08 Antirestenoses protein

Country Status (10)

Country Link
US (1) US5686409A (de)
EP (1) EP0754054B1 (de)
JP (1) JPH10504015A (de)
AT (1) ATE219943T1 (de)
CA (1) CA2187444C (de)
DE (1) DE69430924T2 (de)
DK (1) DK0754054T3 (de)
ES (1) ES2176250T3 (de)
PT (1) PT754054E (de)
WO (1) WO1995027503A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939525A (en) * 1995-03-27 1999-08-17 Viron Therapeutics, Inc. Methods of treating inflammation and compositions therefor
US6818016B1 (en) * 1997-06-27 2004-11-16 The Regents Of The University Of Michigan Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo
EP1210086B1 (de) * 1999-09-09 2006-12-06 Hadasit Medical Research Services & Development Co., Ltd. Verwendung von halofuginone zur behandlung von urethralstriktur
JP2003512436A (ja) 1999-10-27 2003-04-02 アレクサンドラ ルーカス、 移植片拒絶を防止及び治療するための組成物及び方法
AU1943501A (en) * 1999-12-02 2001-06-12 Viron Therapeutics, Inc. Methods of treating inflammation and compositions therefor
US7419670B2 (en) 2000-09-29 2008-09-02 Viron Therapeutics, Inc. Method of treating arthritis with SERP-1 and an immunosuppressant
AU2002211744B8 (en) * 2000-10-11 2008-03-20 Viron Therapeutics, Inc. Nucleic acid molecules and polypeptides for immune modulation
CA2428097A1 (en) * 2000-12-04 2002-06-13 Viron Therapeutics, Inc. Immunomodulatory protein derived from the yaba monkey tumor virus
US7718368B2 (en) * 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
US7285530B2 (en) * 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent
US8251876B2 (en) 2008-04-22 2012-08-28 Hill-Rom Services, Inc. Breathing exercise apparatus
JP2013527125A (ja) * 2009-09-16 2013-06-27 バイロン セラピューティクス インコーポレーテッド 心臓ステント移植を受ける患者を治療する方法
US9180271B2 (en) 2012-03-05 2015-11-10 Hill-Rom Services Pte. Ltd. Respiratory therapy device having standard and oscillatory PEP with nebulizer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171217A (en) * 1991-02-28 1992-12-15 Indiana University Foundation Method for delivery of smooth muscle cell inhibitors

Also Published As

Publication number Publication date
DE69430924T2 (de) 2003-02-27
ES2176250T3 (es) 2002-12-01
WO1995027503A1 (en) 1995-10-19
EP0754054B1 (de) 2002-07-03
US5686409A (en) 1997-11-11
CA2187444A1 (en) 1995-10-19
CA2187444C (en) 2008-07-08
DE69430924D1 (de) 2002-08-08
JPH10504015A (ja) 1998-04-14
EP0754054A1 (de) 1997-01-22
DK0754054T3 (da) 2002-10-14
PT754054E (pt) 2002-10-31

Similar Documents

Publication Publication Date Title
ES2164916T3 (es) Tratamiento de la esclerosis multiple.
AU1373499A (en) Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease
DE69430924T2 (de) Antirestenoses protein
MY131796A (en) Use of glp-1 or analogs in treatment of myocardial infraction
DE68919358T2 (de) Zusammensetzung zur behandlung der schizophrenie.
IL114446A (en) Pharmaceutical preparation for pain management and process for its preparation
FI971420A (fi) Menetelmä diabetes mellituksen hoitamiseksi KGF:ää käyttämällä
DE69625682D1 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
ATE216891T1 (de) Verwendung von immunosuppressiva zur behandlung der schizophrenie
SE9502219D0 (sv) Novel medical use
DE69729201T2 (de) Sulfonfluoride zur behandlung von der alzheimerischen krankheit
SE9504267D0 (sv) New therapeutic use
ES2169124T3 (es) Acido 4-aminomicofenolico 6-sustituido y derivados con actividad inmunosupresora.
ATE184487T1 (de) Transdermales therapeutisches system für silatranverbindungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee